In the present study, the increase in the NOTCH2, EP300, PSEN1, DTX1, JAG2 proteins show that NOTCH signaling pathway is also upregulated in the PMS and RRMS clinical subtypes but not in CIS groups. This evidence concerns the gene NOTCH2 and in situ carcinoma.